Upcoming EventIncreasing diversity in clinical trials

The Covid-19 pandemic has thrown into relief the longstanding racial inequities in the U.S. healthcare system. One major problem: making sure that the studies that test medical treatments reflect the populations of people who will receive them. We’ll search for solutions. 

Speakers:

  • Quita Beeler Highsmith, M.B.A., vice-president and chief diversity officer, Genentech
  • Jonathan Jackson, Ph.D., assistant professor of neurology, director of the CARE Research Center, Massachusetts General Hospital, Harvard Medical School
  • Clyde W. Yancy, M.D., vice dean, diversity & inclusion; Magerstadt Professor of Medicine; professor of medical social sciences; and chief, division of cardiology at the Northwestern University Feinberg School of Medicine
  • Nicholas St. Fleur, Knight-Wallace reporting fellow, STAT (moderator)
  • Kent Thoelke, chief scientific officer & executive vice president, PRA Health Sciences (sponsor introduction)
Share:
Novo Norodisk

Novo Norodisk

Southwest Labs

Southwest Labs

UPS

UPS

AMRI

AMRI

Aerotek

Aerotek

Emera

Emera

Amgen

Amgen

STC UTM

STC UTM

Arrowhead Center

Arrowhead Center

New Mexico Consortium

New Mexico Consortium

Bio

Bio

Burrell College of Osteopathic Medicine

Burrell College of Osteopathic Medicine

Bristol Myers Squibb

Bristol Myers Squibb

Sandia National Laboratories

Sandia National Laboratories